Specific growth factors and the healing of chronic wounds.
Krishnamoorthy
L
L
Wound Healing Research Unit, University of Wales College of Medicine, Cardiff, UK.
Morris
H L
HL
Harding
K G
KG
D002908:Chronic Disease; D004815:Epidermal Growth Factor / Q000502:physiology / Q000627:therapeutic use; D005346:Fibroblast Growth Factors / Q000502:physiology / Q000627:therapeutic use; D015316:Genetic Therapy / Q000379:methods; D006133:Growth Substances / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D010982:Platelet-Derived Growth Factor / Q000502:physiology / Q000627:therapeutic use; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D017768:Skin, Artificial; D013002:Somatomedins / Q000502:physiology / Q000627:therapeutic use; D016212:Transforming Growth Factor beta / Q000502:physiology / Q000627:therapeutic use; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology; D014947:Wounds and Injuries / Q000503:physiopathology / Q000628:therapy*
D006133:Growth Substances; D010982:Platelet-Derived Growth Factor; D013002:Somatomedins; D016212:Transforming Growth Factor beta; D005346:Fibroblast Growth Factors; D004815:Epidermal Growth Factor